Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.
Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs
Lu Wang, Wei Guo, Xiaodong Lee
Cervical cancer is a significant global health concern, necessitating the development of effective therapeutic strategies. However, the success of these strategies is often hindered by drug toxicity, which can lead to adverse effects and treatment discontinuation. Genetic variations among patients play a crucial role in their susceptibility to drug toxicity. In recent years, machine learning techniques have demonstrated remarkable potential in predicting drug responses based on genetic information. In this study, we present a novel approach to predict drug toxicity in cervical cancer patients using machine learning algorithms and genetic data. By leveraging comprehensive genetic profiles and drug toxicity information, we aim to enhance personalized treatment strategies and mitigate the occurrence of adverse drug reactions. This research holds promise in improving the safety and efficacy of cervical cancer treatments, ultimately contributing to better patient outcomes and quality of life.